Abstract
We describe the first report of simultaneous blood infection with KPC-2 producing Klebsiella pneumoniae and Escherichia coli in a Brazilian patient. We highlight the importance of implementing efficient infection control measures to limit the spread of these phenotypes in a hospital setting.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged, 80 and over
-
Amikacin / administration & dosage
-
Anti-Bacterial Agents / administration & dosage
-
Catheter-Related Infections / diagnosis*
-
Catheter-Related Infections / microbiology
-
Community-Acquired Infections / complications
-
Community-Acquired Infections / drug therapy
-
Drug Resistance, Multiple, Bacterial
-
Escherichia coli Infections / complications
-
Escherichia coli Infections / diagnosis*
-
Escherichia coli Infections / microbiology
-
Female
-
Humans
-
Klebsiella Infections / complications
-
Klebsiella Infections / diagnosis*
-
Klebsiella Infections / microbiology
-
Klebsiella pneumoniae* / metabolism
-
Meropenem
-
Pneumonia, Bacterial / complications
-
Pneumonia, Bacterial / drug therapy
-
Thienamycins / administration & dosage
-
beta-Lactamases / metabolism*
Substances
-
Anti-Bacterial Agents
-
Thienamycins
-
Amikacin
-
beta-Lactamases
-
beta-lactamase KPC-2, Klebsiella pneumoniae
-
Meropenem